Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 9Hyperandrogenism 4Neoplasms 3Skin Diseases 1Sarcoma 1Rare Diseases 1Obesity 1Metabolic Syndrome 1Lymphoma 1Leukemia, Myeloid, Acute 1Inflammation 1Hematologic Neoplasms 1Heart Failure 1Glioblastoma 1Endocrine System Diseases 1Critical Illness 1Cardiovascular Diseases 1Cardiotoxicity 1Breast Neoplasms 1Advanced Malignant Neoplasm 1Acute Kidney Injury 1Acanthosis Nigricans 1

Interventions

Metformin 7Magnetic Resonance Spectroscopy 2Inositol 2Exercise 2Ethinyl Estradiol 2maltodextrin 1drospirenone and ethinyl estradiol combination 1drospirenone 1Walking 1Triptorelin Pamoate 1Testosterone 1Sugars 1Spironolactone 1Pyruvic Acid 1Preoperative Exercise 1Pioglitazone 1Phlebotomy 1Pancreaticoduodenectomy 1Orchiectomy 1Leuprolide 1Hepatectomy 1Flutamide 1Etanercept 1Estrogens 1Diet, Reducing 1Diet, Mediterranean 1Diet, Fat-Restricted 1Diet Therapy 1Diet 1Diathermy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Metabolic Syndrome × Spironolactone × Clear all
NCT01526616 2012-02-06

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

University Magna Graecia

Phase NA Completed
56 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡